Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Dr. Reddy's Laboratories

Sector: Healthcare | Industry: Drugs & Pharma
R 2,684.65 32.75  | 1.24% 4.59% 20.73 44,580.23
NSE Price: Oct 15, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 15, 15:59 2,684.65 32.75 1.24% 2,662.00 2,651.90 342,159 2,654.55 - 2,696.90
BSE Oct 15, 2019 2,683.20 34.30 1.29% 2,663.10 2,648.90 11,141 2,659.80 - 2,695.80
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
TTM Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14
Income StatementR Cr
Operating Revenue15,569.9015,448.2014,281.0014,196.1015,568.30 15,023.3013,415.30
Other Income743.90337.50155.20171.50295.00 274.10169.90
Total Income16,313.8015,785.7014,436.2014,367.6015,863.30 15,297.4013,585.20
Total Expenditure12,445.4012,270.0011,929.8011,723.9011,983.00 11,529.7010,164.70
Operating Profit3,868.403,515.702,506.402,643.703,880.30 3,767.703,420.50
Interest99.2088.9078.8063.4082.60 108.20126.70
PBDT3,769.203,426.802,427.602,580.303,797.70 3,659.503,293.80
Depreciation1,145.101,134.801,077.201,026.60938.90 759.90647.50
PBT & Exceptional Items2,624.102,292.001,350.401,553.702,858.80 2,899.602,646.30
Exceptional Items0.00---- --
Profit before Tax2,624.102,292.001,350.401,553.702,858.80 2,899.602,646.30
Provision for Tax525.40385.80438.00296.50751.10 563.20683.10
Profit after Tax2,098.701,906.20912.401,257.202,107.70 2,336.401,963.20
Minority Interest0.00---- --
Share of Associate51.8043.8034.4034.9022.90 --
Consolidated Profit2,150.501,950.00946.801,292.102,130.60 2,336.401,963.20
 
LiabilitiesR Cr
Share Capital83.0083.0083.0082.9085.30 85.2085.10
Total Reserves13,940.6013,861.1012,406.0012,098.8012,393.90 9,677.407,698.60
Shareholder's Funds14,023.6014,023.6012,571.6012,262.1012,569.80 9,853.107,865.20
Minority Interest----- --
Long Term Borrowings2,200.002,200.002,508.90544.901,068.50 1,431.502,075.50
Other Non Current Liabilities344.70297.40375.00427.60345.00 351.20174.40
Current Liabilities5,897.305,897.306,893.808,419.906,347.10 6,821.305,790.40
Total Debt*-3,838.105,071.404,918.503,351.30 4,314.104,477.00
Total Liabilities22,465.6022,418.3022,349.3021,654.5020,330.40 18,457.1015,905.50
 
AssetsR Cr
Net Block9,186.107,191.006,968.006,930.706,563.00 5,377.004,640.80
Non Current Investments334.20334.20465.30682.60329.70 145.600.40
Other Non-Current Assets1,823.903,783.004,417.604,357.501,643.70 1,057.80938.60
Current Investments2,252.902,252.901,833.001,427.103,503.40 2,102.201,066.40
Cash and Bank222.80222.80263.80386.50492.10 1,872.402,300.60
Other Current Assets8,645.708,634.408,401.607,870.107,798.50 7,902.106,958.70
Net Current Assets5,224.105,212.803,604.601,263.805,446.90 5,055.404,535.30
Miscellaneous Exp. Not Written Off----- --
Total Assets22,465.6022,418.3022,349.3021,654.5020,330.40 18,457.1015,905.50
 
Cash FlowR Cr
From Operations-2,870.401,803.002,144.403,262.60 2,523.501,969.70
From Investing Activities--772.70-1,488.30-1,840.40-2,039.40 -2,264.70-1,694.10
From Finance Activities--2,132.60-444.00-369.20-1,700.10 -433.20-24.20
Net Inflow/Outflow--34.90-129.30-65.20-476.90 -174.40251.40
 
Key Ratios
Adjusted EPS (Rs)129.43117.4757.0477.93124.89 137.11115.35
Adjusted Book Value (Rs)879.01840.01752.35734.72731.49 572.92457.33
Dividend per Share (Rs)-20.0020.0020.0020.00 20.0018.00
Cash Flow per Share (Rs)-172.92108.61129.34191.24 148.09115.73
Debt to Equity0.160.280.410.400.27 0.440.58
Current Ratio1.891.881.521.151.86 1.741.78
ROCE (%)-13.418.219.7719.55 22.6924.77
RONW (%)15.7814.427.4010.2018.95 26.6327.88
Operating Margin (%)24.8522.7617.5518.6224.92 25.0825.50
Net Margin (%)12.8612.086.328.7513.29 15.2714.45
Revenue Growth (%)6.038.170.60-8.813.63 11.9912.78
Net Profit Growth (%)58.58108.92-27.43-40.35-9.79 19.0128.58
EPS Growth (%)58.41105.96-26.81-37.60-8.92 18.8728.28
Book Value Growth (%)-11.652.52-2.3827.83 25.4223.55
 
Market Cues
Close Price (Rs)2,684.652,780.252,080.552,632.353,035.20 3,488.752,563.90
High Price (Rs)2,964.002,878.002,787.003,689.854,386.60 3,666.252,939.40
Low Price (Rs)1,872.951,872.951,901.152,555.202,750.05 2,246.501,768.25
Market Cap (Rs Cr)44,580.2346,050.8934,568.6743,646.8551,775.39 59,426.1543,584.82
Price / Earnings20.7323.6236.5133.7824.30 25.4322.20
Price / Book Value3.053.302.773.584.15 6.095.60
Dividend Yield (%)0.750.720.960.760.66 0.570.70
TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
*Total Debt is long term borrowings plus short term borrowings plus current maturities of long term borrowings.
Essential checks
Altman Z-Score
5.43
Piotroski F-Score
9
Modified C-Score
0
5-Years Price to Earnings
20.73
5-Years Price to Book
3.05
Earnings Yield
EBIT / Enterprise value
5.93%
PEG
Price / Earnings to growth ratio
-10.38
Related Stocks
  Current Price   Chng %
Aurobindo Pharma R455.35 -0.85%
Biocon R260.30 +2.74%
Cadila Healthcare R234.45 +0.75%
Cipla R446.55 +1.28%
Divi's Laboratories R1,693.10 +0.56%
Glaxosmithkline Pharma R1,433.15 +2.66%
Lupin R721.15 +0.66%
Piramal Enterprises R1,375.85 -0.05%
Sun Pharmaceutical Inds. R396.80 +0.54%
Torrent Pharmaceuticals R1,699.85 +0.11%
As on Oct 15, 15:59